Analysis of international study shows broad benefits regardless of pre-existing cardiovascular disease or which class of SGLT2 inhibitor SAN DIEGO, June 13, 2017 /PRNewswire-USNewswire/ — A new class of medication, known as sodium-glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalization for heart failure when used to treat patients […]
Espero Pharmaceuticals – a commercial-stage cardiovascular pharma company – and Armetheon – a late-clinical stage pharma company developing innovative novel drugs addressing major unmet needs in cardiovascular diseases – plan to merge.
In honor of American Heart Month, AHA and OH launch new initiative to improve heart health outcomes.
AstraZeneca has signed a wide-ranging deal with private biotech firm Bicycle Therapeutics to develop a novel class of small molecule medicines.
Adults with longer-lived parents have a lower-than-average risk for problems with the body’s circulatory system in middle age, British researchers have found.
(Reuters Health) – People with early Alzheimer’s disease who consumed light to moderate amounts of alcohol every day were less likely to die during a recent one-year study, researchers found. “These results are somewhat surprising because Alzheimer´s disease is a neurodegenerative disease and we know that alcohol can have harmful effects on the brain,” said […]
(Reuters Health) – Young adults who exercise may have a lower risk of cardiovascular disease and higher survival odds decades later than their peers who aren’t as active early in life, a U.S. study suggests. Fitness has long been linked to a reduced risk of heart disease in older adults. The new study, however, offers […]
A tiny salt shaker symbol that warns certain meals are high in sodium will appear, starting Tuesday, on menus in chain restaurants in New York City, the first U.S. city to take the step in an effort to combat heart disease and stroke. Any menu item containing more than 2,300 milligrams (0.08 oz) of sodium, […]
(Reuters Health) – People who drink coffee daily, even up to four cups per day, are less likely to die from heart disease, neurological disease, type 2 diabetes or suicide than others, according to a new study. Researchers did not test how upping coffee consumption would change health outlooks, so they cannot conclude that coffee […]
New York-based Bristol-Myers Squibb Company (BMY) announced today that it is acquiring Chapel Hill, N.C.-based Cardioxyl for up to about $2.07 billion. Cardioxyl focuses on developing drugs for cardiovascular diseases. As part of the deal, Bristol-Myers Squib picks up the company’s lead asset, CXL-1427, a novel nitroxyl (HNO) donor (prodrug) that is currently in […]